Tamiflu treatment may shorten flu isolation time, study suggests
NCT ID NCT04515446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks how long the flu virus stays in the upper airways of 18 hospitalized adults who are taking oseltamivir (Tamiflu). The goal is to see if antiviral treatment can safely shorten the time patients need to stay in isolation, freeing up hospital rooms during flu season. Researchers will also check if the flu type (A or B), vaccination status, or other health conditions affect how long the virus lingers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FLU are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Princesse Grace
Monaco, Municipality of Monaco, 98000, Monaco
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple exercise test may reveal hidden risks in flu patients
- Baby formula with immune boosters may cut colds and flu in infants
- 25,000 volunteers help scientists track COVID, flu, and RSV in real time
- Simple text reminders boost flu vaccination rates in older adults
- Flu's hidden toll on ERs revealed in new study